NASAL VACCINES
- Potential best-in-class vaccination
- Painless
- Non-invasive
- Suitable for all ages
- No hazardous waste
- Generates immunity where needed
- Multi-array antigen-presenting and Th2 cell mimetic
- Compensating for reduced CD4+ cells
- Double-action stimulating:
- Antigen presenting cells
- B cells
- Potential therapeutic as well as prophylactic vaccines
- Potential safety advantages
ORAL VACCINES
- Oral vaccine to generate greater immunity than injectable approaches for the important mucosal surfaces
- More convenient to take (oral, easy-to-swallow)
- Easier to distribute globally
- Lower burden to healthcare systems (self-administration potential)
- No hazardous waste
- Potential safety advantages
RAPID ULTRASENSITIVE HOME SELF-TESTING
- Ultrasensitive biosensor
- Screening multiple viruses/antibodies
- Rapid point-of-care diagnostic
- Self-administered testing
- Readily adaptable to new virus variants
- Mobile-enabled accessible surveillance
- Rapid manufacturing
- Low cost of volume manufacturing
- Stability reducing logistics costs